Research on A1 and A2 milk: A1 milk is not a matter of health concern

NARAYAN G HEGDE

doi:10.56093/ijans.v89i7.92010

Authors

NARAYAN G HEGDE Trustee, BAIF Development Research Foundation, Pune, Maharashtra 411 058 India

https://doi.org/10.56093/ijans.v89i7.92010

Keywords:

A1 milk, A2 milk, Cattle, Health

Abstract

Milk has special significance in Indian mythology, culture and diet. While milk has been considered as a complete food since ages, there are many lobbies, who have been discouraging consumption of milk citing health or cruelty reasons. This review article discusses about the latest controversy about the quality of milk produced by certain exotic breeds of cattle.

Downloads

Download data is not yet available.

References

Brooke-Taylor S, Dwyer K, Woodford K and Kost N. 2017. Systematic review of the gastrointestinal effects of A1 compared with A2 -casein. Advances in Nutrition 8(5): 739–48. DOI: https://doi.org/10.3945/an.116.013953

Cass H, Gringras P, March J, McKendrick I, O’Hare A E, Owen L and Pollin C. 2008. Absence of urinary opioid peptides in children with autism. Archives of Diseases in Childhood 93(9): 745–50. DOI: https://doi.org/10.1136/adc.2006.114389

Chin-Dusting J, Shennan J, Jones E, Williams C, Kingwell B and Dart A. 2006. Effect of dietary supplementation with beta- casein A1 or A2 on markers of disease development in individuals at high risk of cardiovascular disease. British Journal of Nutrition 95(1): 136–44. DOI: https://doi.org/10.1079/BJN20051599

Crawford R A, Boland M J and Hill J P. 2003. Changes over time in the associations between deaths due to ischaemic heart disease and some main food types. Australian Journal of Dairy Technology 58: 183.

Deth R, Clarke A, Ni J and Trivedi M. 2016. Clinical evaluation of glutathione concentrations after consumption of milk containing different subtypes of beta-casein: results from a randomized, cross-over clinical trial. Nutrition Journal 15: 82. DOI: https://doi.org/10.1186/s12937-016-0201-x

EFSA. 2009. Scientific Report of EFSA prepared by a DATEX Working Group on the Potential Health Impact of -Casomorphins and Related Peptides. European Food Safety Authority Science Report, pp 1–107.

Elliott R B. 1992. Epidemiology of diabetes in Polynesia & New Zealand. Epidemiology and Etiology of Insulin-Dependent Diabetes in the Young. (Eds) Levy-Marchal C and Czernichow P. pp 66–71.

Elwood P C, Pickering J E, Hughes J, Fehily A M and Ness A R. 2004. Milk drinking, ischaemic heart disease and ischaemic stroke II. Evidence from cohort studies. European Journal of Clinical Nutrition 58(5): 718–24. DOI: https://doi.org/10.1038/sj.ejcn.1601869

He M, Sun J, Jiang Z Q and Yang Y X. 2017. Effects of cow’s milk beta-casein variants on symptoms of milk intolerance in Chinese adults: a multicentre, randomised controlled study. Nutrition Journal 6: 72. DOI: https://doi.org/10.1186/s12937-017-0275-0

Ho S, Woodford K, Kukuljan S and Pal S. 2014. Comparative effects of A1 versus A2 beta-casein on gastrointestinal measures: a blinded randomised cross-over pilot study. Eur. J. Clin. Nutr. 68(9): 994–1000. DOI: https://doi.org/10.1038/ejcn.2014.127

Hunter L C, O’Hare A, Herron W J, Fisher L A and Jones G E. 2003. Opioid peptides and dipeptidyl peptidase in autism. Dev. Med. Child Neurol. 45(2): 121–28. DOI: https://doi.org/10.1111/j.1469-8749.2003.tb00915.x

Jianqin S, Leiming X, Lu X, Yelland G W, Ni J and Clarke A J. 2016. Effects of milk containing only A2 beta casein versus milk containing both A1 and A2 beta casein proteins on gastrointestinal physiology, symptoms of discomfort, and cognitive behavior of people with self-reported intolerance to traditional cows’ milk. Nutrition Journal 15: 45. DOI: https://doi.org/10.1186/s12937-016-0164-y

Laugesen M and Elliott R. 2003. Ischaemic heart disease, Type 1 diabetes, and cow milk A1 beta-casein. New Zealand Medical Journal 116(1168): U295.

Lucarelli S, Frediani T, Zingoni A M, Ferruzzi F, Giardini O, Quintieri F, Barbato M, D’Eufemia P and Cardi E. 1995. Food allergy and infantile autism. Panminerva Medicine 37(3): 137– 41.

McLachlan C N S. 1996. New Zealand Patent Application 306584. McLachlan C N. 2001. Beta-casein A1, ischaemic heart disease mortality, and other illnesses. Med. Hypotheses. 56(2): 262–72. DOI: https://doi.org/10.1054/mehy.2000.1265

Mishra B P, Mukesh M, Prakash B, Sodhi M, Kapila R and Kishore A. 2009. Status of milk protein, -casein variants among Indian milch animals. Indian Journal of Animal Science 79(7): 722– 25.

Ng-Kwi-Hang K F and Grosclaude F. 1992. Proteins. pp 405–455. Advanced Dairy Chemistry. Elsevier, London.

Sodhi M, Mukesh M, Mishra B P, Kishore A B, Prakash B, Kapil R, Kate K, Khataria R S and Joshi B K. 2012. Screening of taurine and crossbred breeding bulls for A1/A2 variants of - casein gene. Indian Journal of Animal Sciences 82(2): 183– 86.

Sun Z, Zhang Z, Wang X, Cade R, Elmir Z and Fregly M. 2003. Relation of beta-casomorphin to apnea in sudden infant death syndrome. Peptides 24(6): 937–43. DOI: https://doi.org/10.1016/S0196-9781(03)00156-6

Tailford K A, Berry C L, Thomas A C and Campbell J H. 2003. A casein variant in cow’s milk is atherogenic. Atherosclerosis 170(1): 13–19. DOI: https://doi.org/10.1016/S0021-9150(03)00131-X

Truswell A S. 2005. The A2 milk case: a critical review. European Journal of Clinical Nutrition 59(5): 623–31. DOI: https://doi.org/10.1038/sj.ejcn.1602104

UlHaq M R, Kapila R, Sharma R, Saliganti V and Kapila S. 2014. Comparative evaluation of cow -casein variants (A1/A2) consumption on Th2-mediated inflammatory response in mouse gut. European Journal of Nutrition 53(4): 1039–49. DOI: https://doi.org/10.1007/s00394-013-0606-7

Venn B J, Skeaff C M, Brown R, Mann J I and Green T J. 2006. A comparison of the effects of A1 and A2 beta-casein protein variants on blood cholesterol concentrations in New Zealand adults. Atherosclerosis 188(1): 175–78. DOI: https://doi.org/10.1016/j.atherosclerosis.2005.10.020

Wasilewska J, Sienkiewicz-Sz³apka E, KuŸbida E, Jarmo³owska B, Kaczmarski M and Kostyra E. 2011. The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE). Neuropeptides 45(3): 189–95. DOI: https://doi.org/10.1016/j.npep.2011.01.005

Woodford K. 2007. Devil in the milk: Illness, health and politics: A1 and A2 milk. Craig Potton Publishing, Wellington, New Zealand.